Break it Down: PainChek lands first US aged-care customer days after FDA green light
Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.
In this episode, host Tylah Tully unpacks the latest news from PainChek (ASX:PCK), who has already securing its first US customer just days after receiving landmark FDA de Novo clearance for its AI-powered pain assessment and monitoring application.
The company’s first American deal is with Jewish Home Family a leading senior-care organisation in New Jersey.
Watch the video for more.
While PainChek is a Stockhead advertiser, it did not sponsor this content.
Related Topics
Related Stories
UNLOCK INSIGHTS
Discover the untold stories of emerging ASX stocks.
Daily news and expert analysis, it's free to subscribe.
By proceeding, you confirm you understand that we handle personal information in accordance with our Privacy Policy.
